logo
logo
Search stocks & features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
ScreenersScreeners
MoreMore

prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
EMA ScreenerEMA Screener
SMA ScreenerSMA Screener
WMA ScreenerWMA Screener
OHLC ScreenerOHLC Screener
Fibonacci ScreenerFibonacci Screener
VWAP ScreenerVWAP Screener
Pivot Point ScreenerPivot Point Screener
Overlay ScreenerOverlay Screener
Trend Indicator ScreenerTrend Indicator Screener
Volume Based Indicator ScreenerVolume Based Indicator Screener
Overbought/Sold ScreenerOverbought/Sold Screener
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Precious Metals
Gold Price TodayGold Price TodayNew
Silver Price TodaySilver Price TodayNew
Platinum Price TodayPlatinum Price TodayNew
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Sector BoosterSector Booster
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
IPO CalendarIPO Calendar
Economic CalendarEconomic Calendar
Market closedRefreshes 15s
Bajaj Healthcare

Bajaj Healthcare

NSE: BAJAJHCAREBSE 539872Healthcarewww.bajajhealth.com
View MapTV Chart
293.50
1.05−0.36%
DAY292
₹293.50
298
52W272
₹293.50
553
Open296.10
Prev Close294.55
Bid293.48100
Ask293.53100
Volume66.2K67%vs 20D avg
Valuation vs Sector
P/E Ratio▼ 30.0%
43.83vs Sector 62.61
lower = cheaper
P/B Ratio▼ 100.0%
vs Sector 1.85
lower = cheaper
Div Yield
0.33%vs Sector
higher = more income
Market Cap₹0
P/E TTM43.83
Book Value₹167.01
EPS TTM₹6.72
ROCE11.4%
ROE4.27%
D/E46.73
Div Yield0.33%
Valuation

Bajaj Healthcare Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Bajaj Healthcare Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Bajaj Healthcare Ltd trades at a P/E of 43.83×.

the price tag

Valuation

Market Cap
P/E Ratio
watch43.83
P/B Ratio
good
EPS
6.72
the engine

Profitability

ROE
watch4.27%
ROCE
avg11.4%
Net Margin
watch2.58%
Op Margin
watch%
the trajectory

Growth

EPS 5Y
watch%
Revenue 5Y
watch%
Qtr Sales
good11.1%
Qtr Profit
good49.3%
the balance sheet

Financial Health

Debt / Equity
watch46.73
Book Value
167.01
Div Yield
avg0.33%
Promoter Hold.
good59.2%
Financials

Bajaj Healthcare Ltd financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Bajaj Healthcare Ltd, switchable between annual and quarterly views, consolidated or standalone.

Bajaj Healthcare Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current reported EPS of ₹6.72.

all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Bajaj Healthcare segment analysis: revenue and profit mix.

Disclosed business segments at Bajaj Healthcare with their share of revenue and profit, switchable between consolidated and standalone reporting.

Bajaj Healthcare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Investment Thesis

Bajaj Healthcare Ltd investment thesis: bull case, bear case, and the flip lines.

Why someone would buy Bajaj Healthcare Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.

Bajaj Healthcare Ltd's investment case rests on 10 positive markers and 9 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • Robust 49.30% quarterly profit growth indicates strong recent operational performance.

  • Healthy debt-to-equity ratio of 0.48 indicates manageable leverage and lower financial risk.

  • Substantial 59.2% promoter holding reflects strong confidence in long-term prospects.

  • Attractive P/E ratio of 28.30, lower than sector P/E 37.98.

  • Strong 10.07% EBITDA CAGR over five years reflects operational efficiency.

bear case

What can break it.

  • Significant decrease in promoter holding to 59.2% may signal reduced confidence.

  • Low Return on Equity (ROE) of 10.70% compared to industry peers.

  • ROCE of 11.40% is considerably lower than peers, indicating inefficient capital utilization.

  • Negative net profits in recent quarters indicate inconsistent profitability and operational challenges.

  • Poor stock performance with -22.75% YTD return raises investor concerns.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 57. The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 47.23. Balance sheet risk re-prices growth multiples fast.

  • Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.

Shareholding

Bajaj shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Bajaj — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Bajaj Healthcare Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Bajaj Healthcare Ltd is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
Aarti Pharmalabs Ltd
583609.26L ₹ Cr
Best Profit Growth
Biofil Chemicals & Pharmaceuticals Ltd
1318.00 %
Highest Dividend Yield
Procter & Gamble Health Ltd
3.64 %

Peer Comparison

Company Name
AAREYDRUGS
Aarey Drugs & Pharmaceuticals Ltd
AARTIDRUGS
Aarti Drugs Ltd
AARTIPHARM
Aarti Pharmalabs Ltd
AJANTPHARM
Ajanta Pharma Ltd
AKUMS
Akums Drugs & Pharmaceuticals Ltd
ALBERTDAVD
Albert David Ltd
ALIVUS
Alivus Life Sciences Ltd
ALKEM
Alkem Laboratories Ltd
ALPA
Alpa Laboratories Ltd
AMRUTANJAN
Amrutanjan Health Care Ltd
APLLTD
Alembic Pharmaceuticals Ltd
ASTRAZEN
Astrazeneca Pharma India Ltd
AUROPHARMA
Aurobindo Pharma Ltd
BAFNAPH
Bafna Pharmaceuticals Ltd
BAJAJHCARE
Bajaj Healthcare LtdCurrent Stock
BALPHARMA
Bal Pharma Ltd
BIOCON
Biocon Ltd
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Ltd
BLISSGVS
Bliss GVS Pharma Ltd
BLUEJET
Blue Jet Healthcare Ltd
BROOKS
Brooks Laboratories Ltd
CAPLIPOINT
Caplin Point Laboratories Ltd
CIPLA
Cipla Ltd
COHANCE
Cohance Lifesciences Ltd
CONCORDBIO
Concord Biotech Ltd
DCAL
Dishman Carbogen Amcis Ltd
DIVISLAB
Divis Laboratories Ltd
DRREDDY
Dr Reddys Laboratories Ltd
EMCURE
Emcure Pharmaceuticals Ltd
ERIS
ERIS Lifesciences Ltd
FDC
FDC Ltd
GLAND
Gland Pharma Ltd
GLAXO
Glaxosmithkline Pharmaceuticals Ltd
GLENMARK
Glenmark Pharmaceuticals Ltd
GRANULES
Granules India Ltd
GUFICBIO
Gufic BioSciences Ltd
HALEOSLABS
Haleos Labs Limited
HESTERBIO
Hester Biosciences Ltd
HIKAL
Hikal Ltd
INDOCO
Indoco Remedies Ltd
INDSWFTLAB
Ind-Swift Laboratories Ltd
INNOVACAP
Innova Captab Ltd
IOLCP
IOL Chemicals & Pharmaceuticals Ltd
IPCALAB
Ipca Laboratories Ltd
JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd
JBCHEPHARM
J B Chemicals & Pharmaceuticals Ltd
JUBLPHARMA
Jubilant Pharmova Ltd
KILITCH
Kilitch Drugs (India) Ltd
KOPRAN
Kopran Ltd
KREBSBIO
Krebs Biochemicals & Industries Ltd
LASA
Lasa Supergenerics Ltd
LAURUSLABS
Laurus Labs Ltd
LINCOLN
Lincoln Pharmaceuticals Ltd
LUPIN
Lupin Ltd
LYKALABS
Lyka Labs Ltd
MANGALAM
Mangalam Drugs and Organics Ltd
MANKIND
Mankind Pharma Ltd
MARKSANS
Marksans Pharma Ltd
MEDICAMEQ
Medicamen Biotech Ltd
MEDICO
Medico Remedies Ltd
MOREPENLAB
Morepen Laboratories Ltd
NATCOPHARM
Natco Pharma Ltd
NECLIFE
Nectar Lifescience Ltd
NEULANDLAB
Neuland Laboratories Ltd
NGLFINE
NGL Fine Chem Ltd
ONESOURCE
OneSource Specialty Pharma Ltd
ORCHPHARMA
Orchid Pharma Ltd
ORTINGLOBE
Ortin Global Ltd
PANACEABIO
Panacea Biotec Ltd
PFIZER
Pfizer Ltd
PGHL
Procter & Gamble Health Ltd
PPLPHARMA
Piramal Pharma Ltd
RPGLIFE
RPG Life Sciences Ltd
SAILIFE
Sai Life Sciences Ltd
SANOFI
Sanofi India Ltd
SANOFICONR
Sanofi Consumer Healthcare India Ltd
SENORES
Senores Pharmaceuticals Ltd
SHILPAMED
Shilpa Medicare Ltd
SIGACHI
Sigachi Industries Ltd
SMSPHARMA
SMS Pharmaceuticals Ltd
SOLARA
Solara Active Pharma Sciences Ltd
SPARC
Sun Pharma Advanced Research Company Ltd
STAR
Strides Pharma Science Ltd
SUNPHARMA
Sun Pharmaceutical Industries Ltd
SUPRIYA
Supriya Lifescience Ltd
SYNCOMF
Syncom Formulations (India) Ltd
THEMISMED
Themis Medicare Ltd
TORNTPHARM
Torrent Pharmaceuticals Ltd
UNICHEMLAB
Unichem Laboratories Ltd
VALIANTLAB
Valiant Laboratories Ltd
VENUSREM
Venus Remedies Ltd
VINEETLAB
Vineet Laboratories Ltd
VIYASH
Viyash Scientific Ltd
WANBURY
Wanbury Ltd
WINDLAS
Windlas Biotech Ltd
WOCKPHARMA
Wockhardt Ltd
ZIMLAB
Zim Laboratories Ltd
ZYDUSLIFE
Zydus Lifesciences Ltd
Technicals

Bajaj Healthcare Ltd technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Bajaj Healthcare Ltd — derived from the live tape, not yesterday's close.

Bajaj Healthcare Ltd last traded at ₹293.5 with an intraday range of ₹292–₹298.4 — live indicator, pivot and CPR signals below.

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹293.50
LevelPrice (₹)Distance% Δ
R4310.07+16.57+5.64%
R3303.67+10.17+3.46%
R2301.03+7.53+2.57%
R1297.27+3.77+1.28%
PIVOT294.631.130.39%
CURRENT293.50
S1278.07-15.43-5.26%
S2284.47-9.03-3.08%
S3288.23-5.27-1.79%
S4290.87-2.63-0.90%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 294.07P: 294.63TC: 295.20
R1
R2
R3
R4
indicator
LTP: 293.50
PDH: 302.60
PDL: 293.35
● Market Sentiment

BAJAJHCARE is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Average

● Opening Range

Day's range: 296.05 ~ 298.4

● Price Position

Trading Inside opening range

Delivery & Volume

Bajaj Healthcare Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Bajaj Healthcare Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Bajaj Healthcare Ltd stood at 46.5% of traded volume, against a 20-day average of 41.8%.

Avg Delivery (20D)41.8%+4.7 ppt latest vs avg
Highest Delivery53.1%on 29 May
Avg Volume (20D)2.04 L20-day run-rate
Conviction Trend↓ Weakening+4.7 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Bajaj Healthcare announcements: results, concalls, ratings, M&A.

Filings Bajaj Healthcare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Insider Activity

Bajaj Healthcare insider trading: promoter and management activity.

Promoter, director and designated-employee transactions in Bajaj Healthcare as reported to SEBI — buying and selling signals from the people who know the business best.

Bajaj Healthcare insider activity below tracks 12 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).

InsiderCategoryTxn DateActionQuantityValue (₹)Price
SAJANKUMAR RAMESHWARLAL BAJAJInsider18 Mar 2026buy+4.55 L₹15.38 Cr₹338.00
ANIL CHAMPALAL JAINInsider18 Mar 2026buy+4.55 L₹15.38 Cr₹338.00
SAJANKUMAR RAMESHWARLAL BAJAJInsider18 Mar 2026buy+4.55 L₹15.38 Cr₹338.00
ANIL CHAMPALAL JAINInsider18 Mar 2026buy+4.55 L₹15.38 Cr₹338.00
ANIL CHAMPALAL JAINInsider17 Mar 2026buy+7.1 K₹19.91 L₹280.60
ANIL CHAMPALAL JAINInsider17 Mar 2026buy+7.1 K₹19.91 L₹280.60
ANIL CHAMPALAL JAINInsider16 Mar 2026buy+7.6 K₹21.29 L₹280.12
ANIL CHAMPALAL JAINInsider16 Mar 2026buy+7.6 K₹21.29 L₹280.12
ANIL CHAMPALAL JAINInsider13 Mar 2026buy+3.0 K₹8.75 L₹291.50
ANIL CHAMPALAL JAINInsider13 Mar 2026buy+3.0 K₹8.75 L₹291.50
Corporate Actions

Bajaj Healthcare dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Bajaj Healthcare has declared, sequenced by announce and record date.

Bajaj Healthcare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Bajaj Healthcare Ltd: business, sector, key facts.

What Bajaj Healthcare Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Bajaj Healthcare Ltd operates in the Healthcare, listed as NSE: BAJAJHCARE, BSE: 539872.

BAJAJHCARE
Healthcare

Bajaj Healthcare Ltd

NSE · BAJAJHCARE·BSE · 539872·www.bajajhealth.com

Bajaj HealthCare Limited is an Indian pharmaceutical company established in 1993 and headquartered in Thane. Its core business revolves around the development, manufacturing, marketing, and sale of pharmaceutical products across India and internationally. Their offerings span a wide range, catering to the pharmaceutical, nutraceutical, and food industries.

A significant portion of their business involves the production and supply of active pharmaceutical ingredients (APIs). These APIs cover a broad spectrum of therapeutic categories, including treatments for diabetes, infections (antibiotic, antiviral, antifungal), cardiovascular issues, respiratory ailments (anti-asthmatic, bronchodilator), and many others. The extensive list of therapeutic areas indicates a diverse portfolio designed to meet varied market demands.

Beyond APIs, Bajaj HealthCare also manufactures and provides pharmaceutical intermediates. These are crucial chemical compounds used in the synthesis of APIs. The company's production of intermediates demonstrates vertical integration within the pharmaceutical supply chain, allowing for greater control over quality and potentially reducing costs.

Finally, Bajaj HealthCare produces finished dosage forms, offering a variety of formulations such as tablets, capsules, sachets, and vials. This provides a complete solution to customers, offering both the raw materials and the final products. The inclusion of nutraceuticals and food supplements further diversifies their product offerings and expands their market reach.

In summary, Bajaj HealthCare operates as a fully integrated pharmaceutical company, from the production of basic intermediates to the manufacturing and distribution of finished pharmaceutical and nutraceutical products. Their broad therapeutic coverage and diverse product portfolio position them within a competitive market.

company facts
Founded / IPO
Employees
SectorHealthcare
HeadquartersThane, India
Market Cap
Listed OnNSE
leadership21 on record
Mr. Sajankumar Bajaj
Executive Chairman of the Board, Managing Director
Mr. Amit Rajan
Chief Technology Officer
Mr. Anil Jain
Joint Managing Director, Executive Director
Ms. Namrata Bajaj
Whole Time Director
Mr. Pakshal Jain
Whole Time Director
Mr. Sandeep Shah
Non-Executive Non-Independent Director
Mr. Ram Banarse
Non-Executive Independent Director
Mr. Hemant Karnik
Non-Executive Independent Director
Mr. Gopalakrishnan Kesavan
Additional Non-Executive Independent Director
Mrs. Kejal Shah
Non-Executive Independent Director
Mr. Loukik Tipnis
Non-Executive Independent Director
Mr. Sajankumar Rameshwarlal Bajaj
Founder, Chairman & MD
§ ∞ · Plainly Answered

Questions investors ask about Bajaj Healthcare Ltd (BAJAJHCARE).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Bajaj Healthcare Ltd (BAJAJHCARE)?

The current share price of Bajaj Healthcare Ltd (BAJAJHCARE) is ₹293.5. Today, the stock has declined by ₹1.05 (0.36%), trading in a range of ₹292 to ₹298.4. The stock opened at ₹296.1 with a trading volume of 66,224 shares.

02Is Bajaj Healthcare Ltd stock a good investment for long-term?

Bajaj Healthcare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹0 crores, P/E ratio of 43.83, ROE of 4.27%, and ROCE of 11.40%. The dividend yield stands at 0.33%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Bajaj Healthcare Ltd stock?

The 52-week high price of Bajaj Healthcare Ltd (BAJAJHCARE) is ₹552.6, while the 52-week low is ₹272.35. Currently trading at ₹293.5, the stock is 7.5% away from its 52-week low and 46.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Bajaj Healthcare Ltd stock at the current price?

Whether to buy Bajaj Healthcare Ltd stock at ₹293.5 depends on multiple factors. The stock is currently trading with a P/E ratio of 43.83 and P/B ratio of N/A. Today's performance shows a loss of 0.36%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Bajaj Healthcare Ltd and when is the next dividend?

Bajaj Healthcare Ltd offers a dividend yield of 0.33%, which means for every ₹100 invested at the current price of ₹293.5, you can expect to receive approximately ₹0.33 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Bajaj Healthcare Ltd?

Bajaj Healthcare Ltd's key financial metrics include: P/E Ratio: 43.83, P/B Ratio: N/A, ROE: 4.27%, ROCE: 11.40%, Dividend Yield: 0.33%, EPS: ₹6.72, Book Value: ₹167.01, Debt-to-Equity: 46.73, and Current Ratio: N/A. The company's market cap stands at ₹0 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Bajaj Healthcare Ltd stock performing today in the market?

Bajaj Healthcare Ltd stock opened at ₹296.1 and is currently trading at ₹293.5, showing a decline of ₹1.05 (0.36%). The intraday high is ₹298.4 and low is ₹292. The trading volume stands at 66,224 shares, indicating moderate market participation today.

08What is the P/E ratio of Bajaj Healthcare Ltd and what does it indicate?

Bajaj Healthcare Ltd has a Price-to-Earnings (P/E) ratio of 43.83, which means investors are willing to pay ₹43.83 for every ₹1 of earnings. With an EPS of ₹6.72, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Bajaj Healthcare Ltd (BAJAJHCARE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.